Navigation Links
The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
Date:10/9/2007

WHITE PLAINS, N.Y., Oct. 9 /PRNewswire/ -- In an effort to increase access and participation in clinical trials among adult blood cancer patients, The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute have launched a groundbreaking partnership, The Clinical Trial Center for Hematologic Malignancies.

This innovativecollaboration is a unique approach to making blood cancer clinical trials available to patients in their community so they can easily have access to the newest treatments for leukemia, lymphoma and myeloma.

"The challenge of recruiting patients to participate in clinical trials is one of the greatest obstacles to getting new drugs approved," said Louis DeGennaro, Ph.D., the Society chief scientific officer. "In fact, less than 5 percent of adult cancer patients nationally participate in trials."

Other major barriers to recruiting patients into clinical trials include patients' reluctance to leave their own doctors and the requirement to travel to major cities outside of their communities to get treatments and participate in trials. Patients also often view trials as risky.

Cleveland Clinic is uniquely structured to work with the Society to overcome these hurdles. Taussig has 45 oncologists at its main campus and another 20 on staff throughout its regional hospitals in the Cleveland metropolitan area. Patients can easily participate in the center's clinical trials while still remaining with their own doctors. The ability to remain with their own doctors will also go a long way toward alleviating patients' fears about participating in the trials. As a result of the broad reach into the community, the clinic has access to a large volume of patients, so recruiting for clinical trials will be much easier. Patients will have access to promising new therapies and will receive far greater supervision under highly controlled conditions than they would under normal treatment circumstances.

"The beauty of t
'/>"/>

SOURCE Leukemia & Lymphoma Society
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
2. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
3. Promising Results with Epratuzumab and Chemotherapy in Children with Acute Lymphoblastic Leukemia
4. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
5. Major Gene Study Uncovers Secrets of Leukemia
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. Fractionated Radioimmunotherapy With (90)Y-epratuzumab in Non-Hodgkins Lymphoma Appears Safe and Active in a Phase I/II Study
9. Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkins Lymphoma in Europe
10. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
11. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" research ... http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging of ... orthopedic instrument industry has seen rapid development ... 3.28 billion yuan in 2006 to 9.85 billion yuan ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... DIEGO, Nov. 5, 2009 Amylin Pharmaceuticals, Inc. (Nasdaq: ... Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, ... Mark Foletta, senior vice president of finance and chief financial ... , The audio portion of the presentation will be webcast ...
... Virtual Health Technologies, Inc. (OTC Bulletin Board: VHGI) announced ... to sell all health care related assets to Wound Management ... paid $1,000,000 in cash and debt, 4,000,000 shares of WNDM ... WNDM closed at $2.00 per share on 11/4/09 and ...
Cached Medicine Technology:OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010 2OTCBB-VHGI Announces LOI to Sell Certain Assets for $10 Million Cash/Stock to WNDM; With Stock Dividend to be Distributed to Shareholders in 2010 3
(Date:7/9/2014)... hidden ways that cells are regulated, scientists at Rockefeller ... cells more likely to metastasize. , What,s more, the ... blocking two other proteins that are normally linked to ... could have unexpected ties. , The study, which ... , points to the possibility of new cancer therapies ...
(Date:7/9/2014)... More scientific research into the metabolism of stromal support ... the metabolism of these cell types in the development ... diabetes, inflammatory conditions and cancer. That was the conclusion ... KU Leuven in the leading journal Nature . ... sort of wake-up call. The metabolism of cancer cells ...
(Date:7/9/2014)... that fecal transplantation is effective and safe for treating ... the result of a study led by Colleen Kelly, ... Medicine at The Women,s Medicine Collaborative. The study and ... print in the American Journal of Gastroenterology . ... , has increased to epidemic proportions over the past ...
(Date:7/9/2014)... R.I. -- Researchers from The Miriam Hospital ... disease (COPD) who are also depressed have difficulty ... to be particularly true for women, and screening ... as part of treatment. The study and its ... Medicine . , Chronic obstructive pulmonary disease ...
(Date:7/9/2014)... . By looking ... brain structure and function, personality, life experiences and genetics, researchers ... develop binge drinking within the next two years. Impulsivity, hopelessness, ... life events and a family history of drug use contribute ... the child had had a single drink at age 14 ...
Breaking Medicine News(10 mins):Health News:Protein pushes breast cancer cells to metastasize 2Health News:Protein pushes breast cancer cells to metastasize 3Health News:Wake-up call for more research into cell metabolism 2Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:What drives a child to abuse alcohol? 2
... HMSY ) today announced that it will present at the ... held May 18 - 19, 2009 at the InterContinental Hotel ... at 12:00 p.m. ET. HMS Holdings Corp. is the nation,s ... services for government healthcare programs. HMS serves the Medicaid programs ...
... May 13 A multi-million dollar gift from ... the University of Rochester Medical Center,s ... center for investigating and treating neurological conditions such ... and trauma to the brain and spinal cord. ...
... American Massage Therapy Association(R) (AMTA(R)) views the decision by ... opportunity to clarify for the public that prostitutes who ... "The public and massage therapists have a right to ... right of massage therapists," says Judy Stahl, AMTA President. ...
... IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), ... that Adam Singer, M.D., Chairman and CEO of IPC The ... and Modern Physician as one of the ... released by the publications on Monday, May 11th.Jeffrey Taylor, IPC,s ...
... of a landmark drug comparison study published in 2002 in ... for high blood pressure. A scientific team including investigators from ... the findings in the May 11 issue of the ... adults in the United States has high blood pressure, which, ...
... Sunday, May 17, traffic near the University of Washington ... for the 27th annual Nordstrom Beat the Bridge to Beat ... Montlake Closures , From 7:30 a.m. until ... Street to 44th Avenue NE. 520 Ramp Closures ...
Cached Medicine News:Health News:$10 Million Gift to Transform Neuromedicine at URMC 2Health News:$10 Million Gift to Transform Neuromedicine at URMC 3Health News:$10 Million Gift to Transform Neuromedicine at URMC 4Health News:$10 Million Gift to Transform Neuromedicine at URMC 5Health News:AMTA Applauds Craigslist Decision, Calls for Protection of Massage Therapists 2Health News:IPC The Hospitalist Company CEO Adam Singer Named One of 50 Most Powerful Physician Executives 2Health News:New research confirms milestone study on blood pressure meds 2Health News:New research confirms milestone study on blood pressure meds 3Health News:Nordstrom Beat the Bridge to Beat Diabetes Run to Temporarily Suspend Traffic in University District on Sunday, May 17 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: